Cell And Gene Therapies: 2023 Roadblocks And Opportunities
By, Frank Maggiore

From the promise of personalized medicine to the complexities of gene editing, the world of cell and gene therapies is rapidly evolving. The field has seen an increasing number of clinical trials and FDA approvals for new therapies. However, despite the progress, there are still significant roadblocks to overcome in order to fully realize the potential of these treatments.
Here we examine the opportunities presented by emerging technologies and discuss how they're likely to shape the future of medicine. The goal of this analysis is to provide a comprehensive overview of the state of the field and offer insights into how businesses, researchers, and clinicians can navigate the roadblocks and capitalize on the opportunities presented by cell and gene therapies.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.